Baxter International Inc (BAX) - Total Liabilities
Based on the latest financial reports, Baxter International Inc (BAX) has total liabilities worth $13.83 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Baxter International Inc growing its equity to track the company's year-over-year net asset growth rate.
Baxter International Inc - Total Liabilities Trend (1985–2025)
This chart illustrates how Baxter International Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Baxter International Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Baxter International Inc Competitors by Total Liabilities
The table below lists competitors of Baxter International Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aritzia Inc
TO:ATZ
|
Canada | CA$1.83 Billion |
|
Eastroc Beverage Group Co Ltd
SHG:605499
|
China | CN¥16.40 Billion |
|
WISE PLC SPONS.ADR/1
F:6WS0
|
Germany | €17.86 Billion |
|
Moog Inc
NYSE:MOG-A
|
USA | $2.80 Billion |
|
ViaSat Inc
NASDAQ:VSAT
|
USA | $10.50 Billion |
|
Maplebear Inc.
NASDAQ:CART
|
USA | $941.00 Million |
|
American Healthcare REIT, Inc.
NYSE:AHR
|
USA | $2.08 Trillion |
|
Klepierre SA
PA:LI
|
France | €10.80 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Baxter International Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BAX stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Baxter International Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Baxter International Inc (1985–2025)
The table below shows the annual total liabilities of Baxter International Inc from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $13.95 Billion | -25.62% |
| 2024-12-31 | $18.76 Billion | -5.30% |
| 2023-12-31 | $19.81 Billion | -11.54% |
| 2022-12-31 | $22.39 Billion | -8.23% |
| 2021-12-31 | $24.40 Billion | +116.06% |
| 2020-12-31 | $11.29 Billion | +9.84% |
| 2019-12-31 | $10.28 Billion | +30.90% |
| 2018-12-31 | $7.85 Billion | -1.76% |
| 2017-12-31 | $8.00 Billion | +10.03% |
| 2016-12-31 | $7.27 Billion | -39.94% |
| 2015-12-31 | $12.10 Billion | -32.73% |
| 2014-12-31 | $17.98 Billion | +7.43% |
| 2013-12-31 | $16.74 Billion | +24.80% |
| 2012-12-31 | $13.41 Billion | +9.53% |
| 2011-12-31 | $12.24 Billion | +14.51% |
| 2010-12-31 | $10.69 Billion | +7.64% |
| 2009-12-31 | $9.93 Billion | +8.26% |
| 2008-12-31 | $9.18 Billion | +9.52% |
| 2007-12-31 | $8.38 Billion | -0.43% |
| 2006-12-31 | $8.41 Billion | -0.17% |
| 2005-12-31 | $8.43 Billion | -19.29% |
| 2004-12-31 | $10.44 Billion | +0.09% |
| 2003-12-31 | $10.43 Billion | +9.37% |
| 2002-12-31 | $9.54 Billion | +44.84% |
| 2001-12-31 | $6.59 Billion | +8.43% |
| 2000-12-31 | $6.07 Billion | -3.53% |
| 1999-12-31 | $6.30 Billion | -10.49% |
| 1998-12-31 | $7.03 Billion | +15.54% |
| 1997-12-31 | $6.09 Billion | +19.56% |
| 1996-12-31 | $5.09 Billion | -11.18% |
| 1995-12-31 | $5.73 Billion | -8.74% |
| 1994-12-31 | $6.28 Billion | -14.65% |
| 1993-12-31 | $7.36 Billion | +37.31% |
| 1992-12-31 | $5.36 Billion | +7.91% |
| 1991-12-31 | $4.97 Billion | +12.25% |
| 1990-12-31 | $4.42 Billion | +3.95% |
| 1989-12-31 | $4.26 Billion | -21.95% |
| 1988-12-31 | $5.45 Billion | +13.51% |
| 1987-12-31 | $4.80 Billion | +4.96% |
| 1986-12-31 | $4.58 Billion | -3.76% |
| 1985-12-31 | $4.76 Billion | -- |
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more